Guidelines for ATC classification and DDD assignment - WHOCC

B02 ANTIHEMORRHAGICS
B02A ANTIFIBRINOLYTICS
86
This group comprises agents, which inhibit fibrinolytic activity.
Combinations with vitamin K, see B02B - Vitamin K and other
hemostatics.
The DDDs are based on treatment of hemorrhage associated with
fibrinolysis.
B02AA Amino acids
B02AB Proteinase inhibitors
Combinations with aprotinin used as local hemostatics are classified in
B02BC30.
B02B VITAMIN K AND OTHER HEMOSTATICS
B02BA Vitamin K
B02BB Fibrinogen
The DDDs are based on treatment of hemorrhage associated with
different deficiency states (e.g. vitamin K deficiency, deficiency of
different blood coagulation factors etc.).
Preparations containing human fibrinogen for systemic use are
classified here. B02BB01 is reserved for systemic formulations only.
B02BC Local hemostatics
This group comprises gauze, tampons etc. impregnated with hemostatic
agents. Local hemostatics used in dentistry, see A01AD - Other agents
for local oral treatment. Epinephrine injection, see C01C - Cardiac
stimulants excl. cardiac glycosides. Tissue adhesives, e.g. cyanoacrylate
based adhesives, are classified in V03AK. Combination with aprotinin
is allowed in B02BC30.